+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Breast Cancer"

Women's Health Diagnostics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Women's Health Diagnostics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
Breast Cancer Diagnostics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Breast Cancer Diagnostics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Oncologists Market Report 2025 - Product Thumbnail Image

Oncologists Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Mastectomy Reconstruction Implants Market Report 2025 - Product Thumbnail Image

Mastectomy Reconstruction Implants Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Cancer Clinical Decision Tools Market Report 2025 - Product Thumbnail Image

Cancer Clinical Decision Tools Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Oncology Devices Market Report 2025 - Product Thumbnail Image

Oncology Devices Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Womens Health Diagnostics Market Report 2025 - Product Thumbnail Image

Womens Health Diagnostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
HER2 Positive Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2 Positive Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
From
ER Positive, HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

ER Positive, HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
AI in Oncology for Analytical Solutions Market Report 2025 - Product Thumbnail Image

AI in Oncology for Analytical Solutions Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
HER2-Positive Gastric Cancer - Global Strategic Business Report - Product Thumbnail Image

HER2-Positive Gastric Cancer - Global Strategic Business Report

  • Report
  • September 2025
  • 281 Pages
  • Global
From
Radioligand Therapy - Global Strategic Business Report - Product Thumbnail Image

Radioligand Therapy - Global Strategic Business Report

  • Report
  • September 2025
  • 381 Pages
  • Global
From
Chemotherapy At-Home Services - Global Strategic Business Report - Product Thumbnail Image

Chemotherapy At-Home Services - Global Strategic Business Report

  • Report
  • September 2025
  • 179 Pages
  • Global
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • September 2025
  • 224 Pages
  • Global
From
Gynecological Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Gynecological Cancer Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 193 Pages
  • Global
From
Oncology Based In-Vivo CRO - Global Strategic Business Report - Product Thumbnail Image

Oncology Based In-Vivo CRO - Global Strategic Business Report

  • Report
  • September 2025
  • 129 Pages
  • Global
From
Loading Indicator

The Breast Cancer market is a subset of the Women's Health market, focusing on the diagnosis, treatment, and prevention of breast cancer. It includes a range of products and services, from medical devices and pharmaceuticals to patient education and support. Breast cancer is the most common cancer among women worldwide, and the market is driven by the need to improve early detection and treatment outcomes. The Breast Cancer market is highly competitive, with a range of players from large multinationals to small start-ups. Companies in the market include Roche, Novartis, AstraZeneca, Pfizer, Merck, and Johnson & Johnson, as well as smaller players such as Myriad Genetics, Genomic Health, and Natera. Show Less Read more